Marie Precechtelova, Petr Dite, Dana Buckova, Martina Bojkova, Bohuslav Kianicka, David Solil, Jiri Dolina
{"title":"Vitamin D in blood serum and chronic pancreatitis.","authors":"Marie Precechtelova, Petr Dite, Dana Buckova, Martina Bojkova, Bohuslav Kianicka, David Solil, Jiri Dolina","doi":"10.4149/BLL_2024_79","DOIUrl":null,"url":null,"abstract":"<p><p>Patients with chronic pancreatitis are at risk of developing malabsorption and malnutrition. Exocrine pancreatic insufficiency is accompanied by decreased serum micronutrient levels and low vitamin D levels are a frequent finding in up to 60-80% of patients. The aim of our prospective study was to investigate vitamin D in the blood serum of subjects with chronic pancreatitis with the possibility of influencing the reduced vitamin D levels with supplementation therapy.</p><p><strong>Material and methodology: </strong>Fifty patients with chronic pancreatitis and 20 subjects in the control group without gastrointestinal tract diseases, including pancreatic disease, were examined. The vitamin D level in blood serum was determined. The results were evaluated according to the age distribution of subjects with pancreatic disease and according to gender. Patients with low vitamin D levels were treated for 24 weeks with a dose of 1.500.000 IU of vitamin D3 per day, and then blood serum vitamin D levels were determined.</p><p><strong>Results: </strong>In people with chronic pancreatitis, vitamin D levels were statistically significantly reduced compared to the control group. There was no statistically significant relationship of vitamin D with gender and age. Supplementation with vitamin D3 achieved an adjustment of vitamin D level to the level of the control group.</p><p><strong>Conclusion: </strong>Blood serum vitamin D levels are significantly reduced in people with chronic pancreatitis. Its correction by oral vitamin D supplementation was effective. Whether this adjustment of levels will be effective also in terms of e.g. beneficial effect on fibrogenesis will require further representative studies, because the limitation of the interpretation of the results of our study is the smaller number of subjects with chronic pancreatitis (Tab. 4, Ref. 29).</p>","PeriodicalId":55328,"journal":{"name":"Bratislava Medical Journal-Bratislavske Lekarske Listy","volume":" ","pages":"508-512"},"PeriodicalIF":1.5000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bratislava Medical Journal-Bratislavske Lekarske Listy","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.4149/BLL_2024_79","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Patients with chronic pancreatitis are at risk of developing malabsorption and malnutrition. Exocrine pancreatic insufficiency is accompanied by decreased serum micronutrient levels and low vitamin D levels are a frequent finding in up to 60-80% of patients. The aim of our prospective study was to investigate vitamin D in the blood serum of subjects with chronic pancreatitis with the possibility of influencing the reduced vitamin D levels with supplementation therapy.
Material and methodology: Fifty patients with chronic pancreatitis and 20 subjects in the control group without gastrointestinal tract diseases, including pancreatic disease, were examined. The vitamin D level in blood serum was determined. The results were evaluated according to the age distribution of subjects with pancreatic disease and according to gender. Patients with low vitamin D levels were treated for 24 weeks with a dose of 1.500.000 IU of vitamin D3 per day, and then blood serum vitamin D levels were determined.
Results: In people with chronic pancreatitis, vitamin D levels were statistically significantly reduced compared to the control group. There was no statistically significant relationship of vitamin D with gender and age. Supplementation with vitamin D3 achieved an adjustment of vitamin D level to the level of the control group.
Conclusion: Blood serum vitamin D levels are significantly reduced in people with chronic pancreatitis. Its correction by oral vitamin D supplementation was effective. Whether this adjustment of levels will be effective also in terms of e.g. beneficial effect on fibrogenesis will require further representative studies, because the limitation of the interpretation of the results of our study is the smaller number of subjects with chronic pancreatitis (Tab. 4, Ref. 29).
慢性胰腺炎患者有发生吸收不良和营养不良的风险。胰腺外分泌功能不全伴随着血清微量营养素水平的下降,而维生素 D 含量低是高达 60-80% 患者的常见病。我们的前瞻性研究旨在调查慢性胰腺炎患者血清中的维生素 D 含量,以便通过补充治疗影响维生素 D 含量的降低:研究对象: 50名慢性胰腺炎患者和20名无胃肠道疾病(包括胰腺疾病)的对照组患者。测定血清中的维生素 D 水平。根据胰腺疾病患者的年龄分布和性别对结果进行了评估。维生素 D 含量低的患者每天服用 1.500.000 IU 的维生素 D3,治疗 24 周,然后测定血清维生素 D 含量:结果:与对照组相比,慢性胰腺炎患者的维生素D水平在统计学上明显降低。维生素 D 与性别和年龄没有明显的统计学关系。补充维生素 D3 可将维生素 D 水平调整到对照组的水平:结论:慢性胰腺炎患者的血清维生素 D 水平明显降低。结论:慢性胰腺炎患者的血清维生素 D 水平明显降低,通过口服维生素 D 补充剂对其进行纠正是有效的。由于慢性胰腺炎受试者人数较少(参考文献 29,表 4),对我们研究结果的解释存在局限性。
期刊介绍:
The international biomedical journal - Bratislava Medical Journal
– Bratislavske lekarske listy (Bratisl Lek Listy/Bratisl Med J) publishes
peer-reviewed articles on all aspects of biomedical sciences, including
experimental investigations with clear clinical relevance, original clinical
studies and review articles.